Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1923805
Max Phase: Preclinical
Molecular Formula: C31H41NO11S2
Molecular Weight: 667.80
Molecule Type: Small molecule
Associated Items:
ID: ALA1923805
Max Phase: Preclinical
Molecular Formula: C31H41NO11S2
Molecular Weight: 667.80
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc2cc([C@H](C)C(=O)OCC/C(SSC(C)C)=C(\C)N(C=O)CC(=O)OC[C@H]3O[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)ccc2c1
Standard InChI: InChI=1S/C31H41NO11S2/c1-17(2)44-45-25(10-11-41-30(38)18(3)20-6-7-22-13-23(40-5)9-8-21(22)12-20)19(4)32(16-33)14-26(34)42-15-24-27(35)28(36)29(37)31(39)43-24/h6-9,12-13,16-18,24,27-29,31,35-37,39H,10-11,14-15H2,1-5H3/b25-19-/t18-,24+,27+,28-,29+,31-/m0/s1
Standard InChI Key: WBHVZXPXXOFAPN-OTYNLLNUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 667.80 | Molecular Weight (Monoisotopic): 667.2121 | AlogP: 2.71 | #Rotatable Bonds: 15 |
Polar Surface Area: 172.29 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.30 | CX Basic pKa: | CX LogP: 1.28 | CX LogD: 1.28 |
Aromatic Rings: 2 | Heavy Atoms: 45 | QED Weighted: 0.12 | Np Likeness Score: 0.77 |
1. Fan W, Wu Y, Li XK, Yao N, Li X, Yu YG, Hai L.. (2011) Design, synthesis and biological evaluation of brain-specific glucosyl thiamine disulfide prodrugs of naproxen., 46 (9): [PMID:21641697] [10.1016/j.ejmech.2011.05.029] |
Source(1):